Curis Inc CRIS
$0.39
-4.59%
at last close
Market Cap$936,808
P/E Ratio—
Div Yield—
Volume66.9K
52-Week Range
$0.33$34.91
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $43.00 (+11031.2% upside)
Key Stats
- Today's Range
- $0.38 – $0.42
- 50-Day Range
- $0.33 – $2.08
- 52-Week Range
- $0.33 – $34.91
- Volume
- 67K shs
- Average Volume
- 230K shs
- Market Cap
- $936,808
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 68.09%
- Days to Cover
- 1.12
About Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Related Stocks
Compare head-to-head: CRIS vs AMGN·CRIS vs MRNA·CRIS vs HALO·CRIS vs RGEN
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.